LIVN News and Press, LivaNova PLC From 07/16/19

CE Marked Bi-Flow is the only cannula designed to prevent leg ischemia during cardiac procedures requiring femoral artery cannulation LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology company, today launched its innovative arterial femoral cannula, Bi-Flow, designed to p...

Negative Interest Rates? A few years ago, we told the story of a Danish sex therapist who had recently refinanced the mortgage on her workplace and was now pleased to receive a monthly check from her bank in the amount of seven euros. We thought that this illustrated the absurdity of negativ...

The versatile and compact system offers the power and simplicity to support more patients in more places LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology company, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its ne...

Revolutionary therapy system has treated more than 120,000 patients worldwide LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology company, is celebrating the 25th anniversary of its Vagus Nerve Stimulation Therapy ® (VNS Therapy) System. This clinically proven, safe a...

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology company, today announced that Stacy Enxing Seng, a Venture Partner with Lightstone Ventures and former executive at several healthcare and medical technology companies, was elected by the Company’s shareholders to join it...

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology company, will host a conference call to discuss its second quarter 2019 results on Wednesday, July 31, 2019 at 1 p.m. London time (8 a.m. Eastern Daylight Time). The Company will release its second quarter 20...

Quick Take Stoke Therapeutics ( STOK ) has filed to raise gross proceeds of $100 million from a U.S. IPO, according to an S-1 registration statement . The firm is developing therapeutics for severe genetic diseases with a focus on dominant loss-of-function [haploinsufficient] diseases of ...

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology company, today announced Damien McDonald, Chief Executive Officer, and Thad Huston, Chief Financial Officer, will present at the Jefferies Healthcare Conference on Tuesday, June 4 in New York at 11 a.m. Eastern Time. The dis...

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology company, today announced Damien McDonald, Chief Executive Officer, and Thad Huston, Chief Financial Officer, will present at the UBS Global Healthcare Conference on Wednesday, May 22 in New York at 10 a.m. Eastern Time. The ...

LivaNova PLC (LIVN) Q1 2019 Results Earnings Conference Call May 1, 2019, 08:00 AM ET Company Participants Matthew Dodds - Senior Vice President, Corporate Development Damien McDonald - Chief Executive Officer Thad Huston - Chief Financial Officer Melissa Farina - Vice Presiden...